Hsu Tzu-Hui, Chang Tsu-Chung
Genomics Research Center; Academia Sinica ; Taipei, Taiwan, ROC.
Department of Biochemistry; National Defense Medical Center ; Taipei; Taiwan, ROC.
Mol Cell Oncol. 2015 Feb 25;2(4):e999512. doi: 10.1080/23723556.2014.999512. eCollection 2015 Oct-Dec.
We recently reported that retinoic acid receptor responder 3 (RARRES3)-mediated protein deacylation resulted in significant inhibition of the transformed properties of breast cancer cells. This finding suggests a key role of RARRES3 in the regulation of growth signaling and metastasis in cancer cells and as a potential therapeutic target for cancer therapy.
我们最近报道,视黄酸受体反应蛋白3(RARRES3)介导的蛋白质去酰化作用可显著抑制乳腺癌细胞的转化特性。这一发现表明RARRES3在癌细胞生长信号调控和转移过程中起关键作用,并且可作为癌症治疗的潜在靶点。